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In a study comparing sinusoidal wave and brief-pulse ECT in endogenous depression, seizure duration was 
monitored by the cuff method in 29 patients over 180 treatment sessions. Mean seizure duration across all treatments 
was 26.5 sees, and the mean for individual patients across their ECT course ranged from a minimum of 15.7 sees 
tomaximum of38.5 sees. Regression analysis found no variable which significantly predictedmean seizure duration. 
Of the 22 good responders in the study, response to ECT was associated with a mean seizure duration of sees in 
1 patient, ando cs in 11 patients; as just 2 of 7poor responders to ECT had a mean seizure duration of <20 sees 
in 1 patients, <25 sees in 11 patients, of the 22 good responders in the study; as just 2 of 7 poor responders to ECT 
had a mean seizure duration of< 25 sees, it appears that a cuff seizure duration of over 20 sees may suffice for the 
seizure to be therapeutic in depression. With (constant current) brief pulse ECT, seizure threshold significantly 
increased with successive ECTs; thresholds did not however differ between the good and poor responders. There 
was a trend for seizure duration to decrease over time; again, good and poor responders did not differ. These 
findings provide little support for the anticonvulsant hypothesis for the antidepressant effect of ECT, but support 
the literature that ECT exerts an anticonvulsant effect. 
INTRODUCTION 
The ECT seizure duration has received attention on 
many counts. A minimum seizure duration of 20-25 sees 
is recommended to ensure therapeutic benefit while 
seizures lasting for 3 mins or longer are considered to 
increase risk for adverse effects (Royal College of 
Psychiatrists, 1989; American Psychiatric Association, 
1990). Within this window of 25-180 seconds, while no 
evidence exists to suggest that longer seizures are more 
therapeutic (Andrade, 1990), it appears that increased 
seizure duration increases ECT-induced amnesia 
(Abrams, 1988). 
A cumulative seizure duration therapeutic window has 
been suggested to exist (Maletzky, 1978; Kramer, 1983), 
but the evidence for this contention is open to question 
(Andrade, 1990). Seizure duration decreases across the 
ECT course and varies inversely as a function of age, 
seizure threshold, ECT number and barbiturate anaes-
thesia dose, and directly as a function of the stimulus 
intensity [although the relationship may be complex out-
side a narrow range of dosing] (Sackeim et al, 1991). 
Recently, Agarwal et al (1992) found thatseizure duration 
monitoring during ECT is virtually unheard of in India: 
lack of such monitoring in research and clinical practice 
has been criticized (Andrade, 1990; Andrade & Gangad-
har, 1990; Channabasavanna, 1992). 
In view of the above-mentioned importance attached 
to seizure duration monitoring during ECT, the data on 
seizure duration and information related thereto were ex-
amined from a double-blind study that sought to compare 
sinusoidal wave and brief-pulse ECT in endogenous 
depression. Specific issues that were considered were 
mean seizure duration, particularly as characteristics of 
good and poor response to ECT, changes in seizure 
threshold and seizure duration across time- again, par-
ticularly as characteristic of good and poor response and 
potential determinants of the ECT seizure duration. 
MATERIAL AND METHODS 
The sample comprised all untreated endogenously 
depressed patients (definite cases; R.D.C: Spitzer et al, 
1978) identified over a 3 month period in 2 adult 
psychiatry units at the National Institute of Mental Health 
and Neurosciences (NIMHANS), Bangalore. Informed 
consent for participation in the study was obtained in 
writing. Subjects were randomized into sinusoidal wave 
(SW) or brief-pulse (BP) ECT groups. No concurrent 
medication was administered. 
SW ECT was administered using an ECT machine 
designed and assembled in collaboration with the 
Biomedical Engineering Department at NIMHANS (Gan-
gadhar et al, 1988). Visual displays permit a read-off of 
the voltage and amperage of the stimulus delivered during 
the ECT. For the study, the SW stimulus specifications 
were 50 Hz, 140 V, unmodified alternating current 
sinusoidal waves delivered for 0.6 sees. BP ECT was 
delivered using the (constant current) MECTA ECT 
device. The BP stimulus settings were 70Hz, 800 mA, 0.75 
msec width, biphasic rectangular pulse delivered for 0.75 
sees. The current delivered between the electrodes was 
recorded in millicoulombs of charge. 
Modified treatments with thiopentone sodium 
(200mg), succinylcholine (20-30mg) and atropine sul-
phate (0.65mg) were administered with bilateral fron-
totemporal electrode placement on alternate mornings, 
thrice weekly. The duration of the seizure was measured 
by the cuff method (Addersley & Hamilton, 1953) by 2 
observers using stopwatches; the mean value was taken 
for analysis. 
If the subject failed to convulse, the stimulus was 
repeated at the next higher setting of stimulus duration; if 
a convulsion occurred, irrespective of its duration, ECT 
was deemed to have been given. 
The ECT course was discontinued when further benefit 
to the subject was unlikely - i.e., when no clinically 
meaningful reduction in 17 item Hamilton Rating Scale 
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for Depression (Hamilton, 1960) scores was seen after 3 
consecutive ECTs with a minimum of 6 treatments, or 
when depression scores fell to 4 or less, whichever oc-
curred earlier. These criteria are in accordance with the 
observations and findings of McAllister et al (1985), that 
if depressives improve with ECT, improvement will be 
discernable within the fifth treatment in the course, and of 
Barton et al (1973) that no benefit is conferred upon the 
TABLE 1 
Clnlcal characteristics or SW and BP ECT good and poor 
respondent. 
SWgood SWpcor BPgood BPpoor 
responders responders responders responders 
(n=13) (n=1) (n=9) (n=6) 
Agefyrs) 36.0 ±8.0 17 42.9 ±10.7 42.5 ±13.4 
M±SD 
Sex(M:F) 7:6 0:1 5:4 3:3 
Polarity 
unipolar 2 1 2 
bipolar 4 Uncertain 4 1 
uncertain 7 4 3 
Episode 
duration 3.0 ±2.3 2.5 3.9 ±1.5 3.5 ±2.2 
(M ± SO (mths) 
Episode 
number 3.0 ±2.3 1 2.6 ±1.4 2.7 ±1.5 
(M±SD) 
Initial Hamilton 
Dep.score 24.2 ±6.3 28 21.4 ±2.6 26.8 ±5.5 
(M±SD) 
Final Hamilton 
Depscore 1.8 ±24 18 0.9 ±1.8 15.7 ±6.5 
(M±SO) 
as the subject had experienced fewer than 3 affective episodes 
With the exception of final depression scores (p<0.01 responder 
groups vs BP poor responders), when the single SW non-responder 
was excluded, the remaining 3 groups did not differ on any of the 
above variables (Kruskal-Wallts one way ANOVA / Fisher's exact prob-
ability test 
patient by continuing ECT after maximum response is 
obtained. 
A favorable response to ECT was prospectively 
defined as greater than 75% reduction from the initial 
depression scores (Andrade & Gangadhar, 1989). This 
cut-off separated the 'good' from the 'poor' responders. 
The term poor responders embraces both partial response 
and non response categories; since, on the average, some 
80% of endogenous depressives respond to ECT, it was 
felt that to separate partial and nonresponders would yield 
TABLE2 
M±SD treatment details of SW and BP ECT good and poor 
responders. 
SWgood SWpoor BPgood BPpoor 
responders responders responders responders 
(n=13) (n=1) (n=9) (n=6) 
Number of 
ECTs 6.5±2.5 8 5.7 ± 2.5 6.2 ±1.2 
Cumulative 
seizure 




duration 27.1 ±6.0 26.4 25.7 ± 4.6 27.6 ± 7.6 
(sees) 
When the single SW poor responder was excluded, the remaining 3 
groups did not differ on any of the above variables (Kruskal-Wallis one 
way ANOVA). 
subsample sizes that would be too small for analysis. The 
study was double-blind: neither patients nor rater were 
aware of the treatment allotted. 
RESULTS 
Sociodemographic and treatment details of the 29 
patients in the sample are presented in Tables 1 and 2. A 
total of 180 ECTs were administered. The mean seizure 
duration for al 1 patients across all treatments was 26.6 sees. 
Mean seizure duration was < 20 sees in 2 patients -1 good 
responder and 1 poor responder, and was between 20 and 
25 sees in 11 patients -10 good responders and 1 poor 
responder. Mean seizure duration exceeded 25 sees in the 
remaining 11 good and 5 poor responders. 
Astepwise multiple regression analysis was conducted 
to assess the influence of age, sex, stimulus waveform, 
number of treatments received and responder status on 
mean seizure duration; no independent variable predicted 
a significant proportion of the variance in the dependent 
variable- in fact, these 5 variables explained barely 8% of 
the total variance (in mean seizure duration) in the regres-
sion analysis. 
An attempt was made to match the 6 BP poor 
responders in the study with 6 BP good responders and 6 
SW good responders (as there was only 1 SW poor 
responder, this category could not be included) on the 
parameters of age, sex, polarity, episode number and 
duration, and number of treatments received; fortunately, 
despite the limited sample from which these 18 patients 
were drawn, the 3 groups so obtained were reasonably 
comparable. The Mean± SD electrical dose delivered in 
each group for the first 4 as well as the last ECT in the 
course are presented in Table 3. These data were analyzed 
separately for SW and BP patients because SW ECT was 
administered using a constant voltage current device 
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TABLE 3: M ± SD electrical dose (coulombs) delivered at different time points during the ECT course. 
ECTl ECT2 ECT3 ECT4 
SWgoodresponders(N=6) 304.6 ±60.6 348.9 ±41.6 320.8 ±84.9 356.0 ±42.3 306.2 ±76.7 
BPgoodresponders(N=6) 66.5 ±8.6 66.5 ±8.6 70.0 ±10.8 73.5*11.5 80.5 ±20.6 
BPpoorresponders(N=6) 73.5 ±11.5 80.5 ±20.6 84.0 ±18.8 87.5 ± 15.8 91.0 ±17.1 
Statistical inferences are presented in the text 
TABLE 4: M ± SD seizure duration (seconds) at different time points during the ECT course. 
ECfi ECT2 ECTl ECT4 Last ECT 
SWgoodresponders(N=6) 28.1 ± 10.1 27.9±9.3 24.0±8.6 26.8±5.4 25.1±6.7 
BPgoodresponders(N=6) 27.3±7.8 28.1±7.0 27.5±9.5 22.7±9.7 21.1*5.0 
BPpoorresponders(N=6) 34.9 ±14.0 27.9 ± 12.4 24.2 ±13.4 27.8 ±9.1 22.3 ±10.0 
Statistical inferences are presented in the text 
(hence, impedance variations would confound SW but not 
BP stimulus dosages). 
A 6x5 one way repeat measures analysis of variance of 
the SW dosage data revealed no significant changes in the 
repeating measure. A 2x5 two way repeat measures 
analysis of variance of the BP dosage data revealed a 
significant main effect for ECT number (F4.40 = 7.72; 
p<0.001) but no significant main effect for response status 
nor a significant response x ECT number interaction. The 
Tukey's honestly significant difference (post hoc) test 
found significant differences across alternate ECT time 
points - i.e., between ECTs 1&3, 2&4, and 3 and the last 
in the course. The Mean ± SD seizure duration at these 
ECT points in these 18 patients are presented in Table 4. 
A 3x5 two way repeat measures analysis of variance 
revealed a near significant main effect for ECT number 
(F4.60 = 2.30; p=0.075) but no significant main effect for 
waveform/response status nor a significant 
waveform/response X ECT number interaction. 
DISCUSSION 
As a number of patients who showed good response to 
ECT had a mean seizure duration <25 sees (in one patient 
it was just 18.7secs!), it appears that there are no grounds 
to consider motor seizure durations (as measured by the 
cuff method) between 20 and 25 sees to be invariably sub 
therapeutic. This may be restated as follows: Motor seizure 
durations of 2 20 sees are likely to suffice for therapy. 
Further work is required to evaluate the significance of 
motor seizures between 15 and 20 sees in duration. 
The cuff method underestimates the EEG seizure dura-
tion by about 10% (Fink & Johnson, 1982) or by a mean 
of 13 sees. (Warmflash et al, 1987). Therefore, a motor 
seizure duration in the region of 20 sees is almost certain 
to be represented by an EEG seizure close to or in excess 
of 25 sees. Official available guidelines (e.g. Royal Col-
lege of Psychiatrists, 1989; American Psychiatric Associa-
tion, 1990) do not specify the lower limit of acceptability 
of seizure duration with specific reference to the method 
of monitoring; the findings of this study may perhaps be 
helpful in this regard, particularly, as the cuff method is 
convenient, practical and inexpensive relative to the EEG 
method and eminently suitable for routine use in develop-
ing countries such as India. (Andrade, 1990; Agarwal et 
al, 1992; Channabasavanna, 1992). 
None of the independent variables entered into the 
regression analysis significantly predicted mean seizure 
duration. The non significance of sex (Sackeim et al, 
1991), stimulus waveform (Andrade et al, 1988) and 
responder status (Andrade, 1990) have some support in 
literature. Age, nonsignificant in this study, has been 
shown to be associated with shorter seizure durations in 
another study (Sackeim et al, 1991); it is possible that the 
considerably older sample in that study may have been 
responsible for this finding. In other words, the effect of 
age on seizure duration may become identifiable only 
beyond a certain range. 
Curiously, the number of treatments received also did 
not influence seizure duration. Since the seizure duration 
decreases with successive ECT (Sackeim et al, 1986), a 
lager number of treatments could have been expected to 
be associated with a shorter mean seizure duration (Net-
telbladt, 1988). A possible explanation for differences 
across studies is the parameter chosen for analysis - mean 
seizure duration (this study), cumulative seizure duration 
(Andrade et al, 1988), seizure duration at a particular 
treatment number (Sackeim et al, 1986) etc. The impor-
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tance of this dependent variable issue is clearly seen from 
the results of the analysis of data in Table 4. 
It may be noted that 2 sources of variance in seizure 
duration - seizure threshold and dose of barbiturate anaes-
thesia - were not addressed in the analysis because the 
former was not formally titrated for (Sackeim et al, 1986) 
while the latter was kept constant for all patients. 
Maletzky (1978) considered that recovery with ECT 
occurred within a therapeutic window of cumulative 
seizure duration between 210 and 1000 sees. From Table 
2 it is clear that a considerable proportion of patients 
showed good response to ECT at cumulative seizure dura-
tions well below the minimum specified by Maletzky. This 
substantiates the opinion that the number of treatments 
received is more important than the cumulative seizure 
duration construct. 
Although the seizure threshold was not formally 
titrated for, with constant current BP ECT the electrical 
dose required to elicit a convulsion was found to increase 
with successive ECT. This is in accordance with the 
findings of Sackeimetal (1987) in a study in which careful 
ti tration of the seizure threshold was undertaken across the 
ECT course. The lack of change in dosing in the SW group 
can be attributed to two factors: [a] the delivered stimulus 
was of the constant voltage type and hence subject to the 
vagaries of interelectrode impedance (across patients, and 
in the same patient across time); and [b] on just 1 occasion 
in just 1 SW ECT patient was it necessary to increase the 
stimulus duration to obtain a convulsion (suggesting that 
the stimulus settings were clearly suprathreshold for the 
group as a whole). 
The absence of difference in dose requirements be-
tween BP ECT good and poor responders and the absence 
of difference in the rate of change of dose requirements 
across the ECT course between BP ECT good and poor 
responders suggest that changes in seizure threshold are 
not germane to treatment response. These findings directly 
contradict the observations of Sackeim et al (1987) that 
proportionately greater increases in seizure threshold char-
acterize good response to ECT. 
The decrease in seizure duration with successive ECT 
is in accordance with literature (Sackeim et al, 1986; 
Michele et al, 1991). The present study further suggests 
that seizure duration changes are unrelated to treatment 
response. Overall, therefore, Tables 3 & 4 confirm that 
ECT has an anticonvulsant action (progressive decrease in 
seizure duration) but do not support the hypothesis that 
this anticonvulsant action is related to the antidepressant 
response (Sackeim et al, 1986; Andrade, 1992) - vide the 
lack of relationship between seizure threshold and seizure 
duration changes on the one hand and responder status on 
the other hand. It is acknowledged, however, that the small 
subgroup sizes could have decreased the power of the 
statistical tests to identify a significant association be-
tween anticonvulsant construct and antidepressant 
response; the absence of a perfect one to one subgroup 
matching is however unlikely to be of importance as none 
of the variables (selected for conventional reasons) on 
which comparison was undertaken have been shown to 
meaningfully affect response to ECT (Andrade, 1990). 
The preliminary observations herein reported may how-
ever bear substantiation with a larger sample and better 
matched subgroups. 
ACKNOWLEDGEMENTS 
Dr. Harold Sackeim, State University of New York at 
New York State Psychiatric Institute, is gratefully ac-
knowledged for the supply of technical manuscripts. Drs. 
Shekar Seshadri, Sanjeev Jain, G. Swaminath, B.N. Gan-
gadhar and S.M. Channabasavanna are acknowledged for 
their contributions to the original study from which these 
data were derived. 
REFERENCES 
Abrams, R. (1986) Electroconvulsive Therapy. New 
York: Oxford University Press. 
Addersley, D. & Hamilton, M. (1953) Use of succinyl-
choline in ECT. British Medical Journal, 1,195-197. 
Agarwal, A.K., Andrade, C. & Reddy, M.V. (1992) 
Electroconvulsive therapy in India: A survey of the 
Indian Psychiatry Society. Paper presented at the 44th 
Annual Conference of the Indian Psychiatric Society, 
New Delhi. 
American Psychiatric Association (1990) The practice 
of ECT: Recommendations for practice, training and 
privileging. Task force report on ECT. Washington, 
DC: American Psychiatric Press. 
Andrade, C. (1990) Psychobiological frontiers of 
electroconvulsive therapy in depression: Evaluation of 
strategies for rational prescription and reduction in 
morbidity [Tilak Venkoba Oration]. Indian Journal of 
Psychiatry, 32, 109-130. 
Andrade, C. (1992) The mechanisms of action of ECT. 
In Proceedings of the National Workshop on ECT: 
Priorities for Research and Practice in India (ed. 
B.N.Gangadhar), pp 107-130. Bangalore: NIMHANS. 
Andrade, C. & Gangadhar, B.N. (1990) Althesin in 
modified ECT. Indian Journal of Psychiatry, 32, 206-
207. 
Andrade,C. & Gangadhar, B.N. (1989) When isan ECT 
responder an ECT responder? Convulsive Therapy, 5, 
190-191. 
Andrade, C, Gangadhar, B.N., Subbakrishna, D.K., 
Channabasavanna, S.M. & Pradhan, N. (1988) A 
double blind comparison of sinusoidal wave and brief 
pulse electroconvulsive therapy in endogenous depres-
sion. Convulsive Therapy, 4, 297-305. 
Barton, J.L., Mehta, S. & Snaith, R.P. (1973) The 
prophylactic value of extra ECT in depressive illness. 
Acta Psychiatrica Scandinavica, 49, 386-392. 
Channabasavanna, S.M. (1992) Indian Psychiatry at the 
crossroads: What we can do with what we have? 
Presidential address to the 44th Annual Conference of 
the Indian Psychiatric Society, New Delhi. 
46 ECT SEIZURE DURATION IN DEPRESSION 
Fink, M. & Johnson, L. (1982) Monitoring the duration 
of electroconvulsive therapy seizures. Archives of 
General Psychiatry, 39,1189-1191. 
Gangadhar, B.N., Lakshmanna, G., Andrade, C, 
Janakiramaiah, N. & Channabasavanna, S.M. 
(1988) The NIMHANS Model ECT Instrument: A 
technical report. Indian Journal of Psychiatry, 30, 
247-251 & 31, 2,1. 
Hamilton, M. (1960) A rating scale for depression. Jour-
nal of Neurology, Neurosurgery and Psychiatry, 23, 
56-62. 
Kramer, BA. (1983) Seizure parameters in depressed 
patients receiving electroconvulsive therapy: A pilot 
study. Comprehensive Psychiatry, 24, 259-261. 
Maletzky, B.M. (1978) Seizure duration and clinical ef-
fect in electroconvulsive therapy. Comprehensive 
Psychiatry, 19, 541-550. 
McAllister, T.W., Price, T.R.P. & Ferrell, R.B. (1985) 
Bilateral sinusoidal ECT following poor response to 
five unilateral brief pulse ECTs. Journal of Clinical 
Psychiatry, 46, 430-431. 
Michele, V. di, Rossi, A., Cataldo, S. de, Nistico, R., 
Giordano, L., Sabatini, M.D., Stratta, P. & Casac-
chia, M. (1991) EEG seizure duration in ECT. Paper 
presented at the 5th World Congress of Biological 
Psychiatry, Florence. 
Chittaranjan Andrade, Assistant Professor, Dept. of. 
Nettelbladt, P. (1988) Factors influencing number of 
treatments and seizure duration in ECT: drug treat-
ment, social class. Convulsive Therapy, 4, 160-168. 
Royal College of Psychiatrists (1989) The Practical 
Administration of Electroconvulsive Therapy. Lon-
don: Gaskell. 
Sackeim, HA., Decina, P., Prohovnik, I., Portnoy, S., 
Kanzler, M. & Malitz, S. (1986) Dosage, seizure 
threshold and the antidepressant efficacy of ECT. An-
nals of the New York Academy of Sciences, 462, 398-
410. 
Sackeim, HA., Decina, P., Portnoy, S., Neeley, P. & 
Malitz, S. (1987) Studies of dosage, seizure threshold 
and seizure duration in ECT. Biological Psychiatry, 
22,249-268. 
Sackeim, HA., Devanand, D.P. & Prudic, J. (1991) 
Stimulus intensity, seizure threshold and seizure dura-
tion: Impact on the efficacy and safety of electrocon-
vulsive therapy (in press) 
Spitzer, R.L., Endicott, J. & Robins, E. (1978) Research 
Diagnostic Criteria, Instrument no.58. New York: 
New York State Psychiatric Institute. 
Warmflash, V., Stricks, L., Sackeim, HA., Neeley, P. 
& Malitz, S. (1987) Reliability and validity of seizure 
duration measures. Convulsive Therapy, 3,18-25. 
;hophemenogy, NIMHANS, Bangalore 560 029. 
47 